MedTrace Logo

Rapid Agitation Control With Ketamine in the Emergency Department

NCT03375671 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-11-30

No results posted yet for this study

Summary

Compare intramuscular (IM) ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the emergency department with psychomotor agitation and violent behavior.

Conditions

  • Violent Aggressive Behavior
  • Ketamine

Interventions

DRUG

Ketalar

single administration of 5 mg/kg, IM

DRUG

Midazolam injection

single administration of 5 mg, IM

DRUG

Haloperidol

single administration of 5 mg, IM

Sponsors & Collaborators

  • St Paul's Emergency Department Research Fund

    collaborator UNKNOWN

  • Centre for Health Evaluation and Outcome Sciences (CHÉOS)

    collaborator UNKNOWN

  • David Barbic

    lead OTHER

Principal Investigators

  • David Barbic, MD MSc FRCPC, · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-29
Primary Completion
2020-03-12
Completion
2020-03-12

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375671 on ClinicalTrials.gov